Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer

Author： Shim Ki-Nam   Jung Sung-Ae   Joo Yang-Hee   Yoo Kwon  

Publisher： Springer Publishing Company

ISSN： 0944-1174

Source： Journal of Gastroenterology, Vol.42, Iss.2, 2007-02, pp. : 120-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Matrix Metalloproteinases and Their Tissue Inhibitors in Endocrinology

By Salamonsen L.A.  

Trends in Endocrinology and Metabolism, Vol. 7, Iss. 1, 1996-01 ,pp. : 28-34

Elsevier

Access to resources Recommend Favorite

Serum Levels of Matrix Metalloproteinases-2 and -9 and Their Tissue Inhibitors in Inflammatory Neuromuscular Disorders

By  

European Neurology, Vol. 55, Iss. 4, 2006-08 ,pp. : 204-208

Karger

Access to resources Recommend Favorite

The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases

By  

Digestive Diseases, Vol. 30, Iss. 3, 2012-06 ,pp. : 289-295

Karger

Access to resources Recommend Favorite

Serum Levels of Matrix Metalloproteinases: Implications in Clinical Neurology

By  

European Neurology, Vol. 67, Iss. 2, 2012-01 ,pp. : 121-128

Karger

Access to resources Recommend Favorite

Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis

By Salata Ireneusz   Stojanovic Nemanja   Cajdler-Łuba Agata   Lewandowski Krzysztof   Lewinski Andrzej  

Gynecological Endocrinology, Vol. 24, Iss. 6, 2008-01 ,pp. : 326-330

Informa Healthcare

Access to resources Recommend Favorite